140 related articles for article (PubMed ID: 11013012)
41. A detailed analysis of the C5a anaphylatoxin effector domain: selection of C5a phage libraries on differentiated U937 cells.
Hennecke M; Otto A; Baensch M; Kola A; Bautsch W; Klos A; Köhl J
Eur J Biochem; 1998 Feb; 252(1):36-44. PubMed ID: 9523709
[TBL] [Abstract][Full Text] [Related]
42. Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells.
Monk PN; Pease JE; Marland G; Barker MD
Eur J Immunol; 1994 Nov; 24(11):2922-5. PubMed ID: 7957584
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
Nitta H; Wada Y; Kawano Y; Murakami Y; Irie A; Taniguchi K; Kikuchi K; Yamada G; Suzuki K; Honda J; Wilson-Morifuji M; Araki N; Eto M; Baba H; Imamura T
Clin Cancer Res; 2013 Apr; 19(8):2004-13. PubMed ID: 23287562
[TBL] [Abstract][Full Text] [Related]
44. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils.
Eglite S; Plüss K; Dahinden CA
J Immunol; 2000 Aug; 165(4):2183-9. PubMed ID: 10925305
[TBL] [Abstract][Full Text] [Related]
45. Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system.
Gasque P; Singhrao SK; Neal JW; Götze O; Morgan BP
Am J Pathol; 1997 Jan; 150(1):31-41. PubMed ID: 9006319
[TBL] [Abstract][Full Text] [Related]
46. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
47. Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor.
Cain SA; Woodruff TM; Taylor SM; Fairlie DP; Sanderson SD; Monk PN
Biochem Pharmacol; 2001 Jun; 61(12):1571-9. PubMed ID: 11377387
[TBL] [Abstract][Full Text] [Related]
48. N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation.
McCoy R; Haviland DL; Molmenti EP; Ziambaras T; Wetsel RA; Perlmutter DH
J Exp Med; 1995 Jul; 182(1):207-17. PubMed ID: 7540650
[TBL] [Abstract][Full Text] [Related]
49. C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells.
Fayyazi A; Sandau R; Duong LQ; Götze O; Radzun HJ; Schweyer S; Soruri A; Zwirner J
Am J Pathol; 1999 Feb; 154(2):495-501. PubMed ID: 10027407
[TBL] [Abstract][Full Text] [Related]
50. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
[TBL] [Abstract][Full Text] [Related]
51. Expression of an epitope tagged human C5a receptor and antibody-mediated immobilization of detergent-solubilized receptor for drug discovery screening.
Sloan DD; Barrett RW; Tate EH; England BP
Protein Expr Purif; 1997 Oct; 11(1):119-24. PubMed ID: 9325147
[TBL] [Abstract][Full Text] [Related]
52. Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells.
Schieferdecker HL; Schlaf G; Jungermann K; Götze O
Int Immunopharmacol; 2001 Mar; 1(3):469-81. PubMed ID: 11367531
[TBL] [Abstract][Full Text] [Related]
53. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization.
Ali H; Richardson RM; Tomhave ED; Didsbury JR; Snyderman R
J Biol Chem; 1993 Nov; 268(32):24247-54. PubMed ID: 8226971
[TBL] [Abstract][Full Text] [Related]
54. Anaphylatoxin C5a receptor mRNA is strongly expressed in Kupffer and stellate cells and weakly in sinusoidal endothelial cells but not in hepatocytes of normal rat liver.
Schieferdecker HL; Rothermel E; Timmermann A; Götze O; Jungermann K
FEBS Lett; 1997 Apr; 406(3):305-9. PubMed ID: 9136907
[TBL] [Abstract][Full Text] [Related]
55. Function, structure and therapeutic potential of complement C5a receptors.
Monk PN; Scola AM; Madala P; Fairlie DP
Br J Pharmacol; 2007 Oct; 152(4):429-48. PubMed ID: 17603557
[TBL] [Abstract][Full Text] [Related]
56. C5a stimulus-secretion coupling in rat basophilic leukaemia (RBL-2H3) cells transfected with the human C5a receptor is mediated by pertussis and cholera toxin-sensitive G proteins.
Monk PN; Pease JE; Barker MD
Biochem Mol Biol Int; 1994 Jan; 32(1):13-20. PubMed ID: 8012277
[TBL] [Abstract][Full Text] [Related]
57. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
[TBL] [Abstract][Full Text] [Related]
58. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis.
Reiman R; Gerard C; Campbell IL; Barnum SR
Eur J Immunol; 2002 Apr; 32(4):1157-63. PubMed ID: 11932923
[TBL] [Abstract][Full Text] [Related]
59. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
Zahn S; Zwirner J; Spengler HP; Götze O
Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
[TBL] [Abstract][Full Text] [Related]
60. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
